Related Experiment Video
Updated: May 26, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia
Andrew J Erie1, Rebecca F McClure, Alexandra P Wolanskyj
1Mayo Medical School.
Abstract:
Bone marrow infiltration by granulomas rarely presents with cytopenias and is usually a result of atypical infections, lymphomas, or sarcoidosis. Drugs are also an important but often overlooked causal agent of bone marrow granulomas. Although rare, amiodarone has been associated with bone marrow granuloma formation. This case report describes a 73-year-old male who presented with pancytopenia during a preoperative evaluation. Amiodarone therapy was suspected to be the causal agent after diagnostic evaluation and exclusion of other causes. After cessation of amiodarone, the patient's pancytopenia gradually resolved over a period of several months. Our report illustrates an often overlooked yet important cause of reversible pancytopenia owing to suspected amiodarone-induced bone marrow granuloma formation, and guides clinicians in an expected timeline for blood count improvement after cessation of this drug.
Insights
Amiodarone can cause bone marrow granulomas, leading to pancytopenia. Discontinuing amiodarone therapy can reverse these blood count abnormalities over several months.
Area of Science:
- Hematology
- Pharmacology
- Pathology
Background:
- Bone marrow granulomas are uncommon and typically linked to infections, lymphomas, or sarcoidosis.
- Drug-induced bone marrow granulomas are an underrecognized cause of hematologic abnormalities.
- Amiodarone is a rare but documented cause of bone marrow granuloma formation.
Observation:
- A 73-year-old male presented with pancytopenia during a preoperative assessment.
- Diagnostic evaluation excluded other causes, leading to suspicion of amiodarone therapy.
- Bone marrow biopsy revealed granulomas, consistent with amiodarone-induced pathology.
Findings:
- Suspected amiodarone-induced bone marrow granuloma formation was identified as the cause of pancytopenia.
- Cessation of amiodarone therapy resulted in the gradual resolution of pancytopenia.
- Blood counts improved over several months following drug discontinuation.
Implications:
- Highlights amiodarone as a potential cause of reversible pancytopenia.
- Emphasizes the importance of considering drug etiologies for bone marrow granulomas.
- Provides a clinical timeline for expected recovery after amiodarone cessation.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Graves Disease II: Pathophysiology
Myocarditis I: Introduction
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Drug toxicity: Idiosyncratic Reactions
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

